Ibuprofen Linked to Kidney Failure in Mild Disease
Johns Hopkins researchers warn that over the counter ibuprofen can trigger acute kidney failure in patients with mild undiagnosed kidney impairment. In a three year study, 12 women with arthritis and high blood pressure showed rapid kidney changes at high doses, with several episodes reversible after stopping the drug. The study urges stronger warnings but stops short of pulling ibuprofen from shelves.
MENTIONED IN THIS ARTICLE
Philadelphia
Advil
Medipren
Mowin
Nuprin
Annals of Internal Medicine
Johns Hopkins University
Baltimore
Andrew Whelton
Michael Murray
Purdue University
Craig Brater
Indiana University
Scientists identify sex of 3 day embryo in vitro
New York AP reports researchers identify the sex of 3 day embryos grown in a test tube and expect twin girls from two implanted cases this summer. The work aims to screen embryos for genetic diseases and avoid abortions, while noting ethical concerns about non medical sex selection.
MENTIONED IN THIS ARTICLE
New York
Alan Handyside
Handyside
Nature
Royal Postgraduate Medical School
Hammsmith Hospital
London
New Orleans
Maria Bustille
Genetics and
IVF Institute
Fairfax
Fiber shown to reduce cancer risk
Washington AP reports a government study finds that doubling daily fiber and vegetable intake may cut colon cancer risk by about 49 percent. The Journal of the National Cancer Institute reviewed 37 studies since 1973, noting strong evidence that fiber and vegetables protect against colon cancer. Bruce Trock of Fox Chase Cancer Center says the data are powerful and clear, though no precise fiber amount is identified.
MENTIONED IN THIS ARTICLE
Washington
Journal of the National Cancer Institute
Bruce Trock
Fox Chase Cancer Center
Philadelphia
Trock
Mr. Trock
NCI
Drug shows promise against hairy cell leukemia
An experimental cancer drug 2-CdA produced complete remissions in 11 of 12 hairy cell leukemia patients after a single seven day course with no relapses to date. The study led by Dr. Lawrence D. Piro reports minimal side effects and potential as the drug of choice, with Scripps to distribute pending FDA approval.
MENTIONED IN THIS ARTICLE
Boston
New England Journal of Medicine
Lawrence D. Piro
Scripps Clinic and Research Foundation
la Jolla
Calif
Scripps
Johnson & Johnson
Ortho Pharmaceuticals
U.S. Food and Drug Administration
Also Mentioned on This Page
Paquette Russ
Catalina Jbj Erno
Haggar
Orig
RBC
Toni Cai
Fox
Frederick Towne